Where to Inject CJC-1295/Ipamorelin: Sites, Timing
CJC-1295/Ipamorelin is a single subcutaneous injection, and for this stack the two decisions that matter most are where you put it and when. The four standard sites all work, but bedtime timing and an empty stomach change the result more than site choice does. Here is the practical guide patients ask for after their first vial arrives.

In this article
Key Takeaways
- CJC-1295/Ipamorelin is a subcutaneous injection, not intramuscular. The needle enters the fat layer just beneath the skin at a 45 to 90 degree angle.
- Four standard sites: abdomen (at least 2 inches from the navel), front or outer thigh, upper outer glute, and back of the deltoid. Abdomen is the most common.
- This is one combined vial, so it is a single injection, not two. Both peptides are already blended in the solution you draw up.
- Timing matters more than site: inject at bedtime on an empty stomach so the peptide-driven pulse stacks on top of your natural nighttime growth hormone release.
- Rotate at least one inch from the previous injection point every time, and rotate body regions every few injections. Always follow your provider prescription.
CJC-1295/Ipamorelin Injection Quick Facts
Route
Subcutaneous (under the skin, not into muscle)
Injections
One combined vial, so a single injection, not two
Standard Sites
Abdomen, thigh, upper glute, back of deltoid
Most Common Site
Abdomen (consistent absorption, easy to see)
Needle
27-31 gauge insulin syringe, 1/2 inch length
Best Time
Bedtime, on an empty stomach
One Vial, One Subcutaneous Injection
CJC-1295/Ipamorelin arrives as a single combined vial. Both peptides are already blended in the solution, so you draw up once and inject once. There is no mixing, and there is no separate ipamorelin shot. If peptides are new to you, what peptide therapy is covers the fundamentals first, and the full how-to-inject-peptides guide walks through the subQ technique step by step. This page focuses on what is specific to this stack: where to put it, when to inject it, and why the timing carries more weight than the location.
The route is subcutaneous. The needle enters the fat layer just beneath the skin at a 45 to 90 degree angle, not the muscle. That keeps absorption steady and avoids the soreness that comes with deeper intramuscular shots. For the science behind why these two peptides are paired, the full CJC-1295/Ipamorelin stack guide covers mechanism, benefits, and the results timeline.
The Four Standard Sites
Four anatomical regions work for any subQ peptide injection, including this one. Each has slightly different absorption characteristics and ergonomics.
1. Abdomen. The area between the lower rib cage and the hip bones, avoiding a roughly two-inch radius around the navel. This is the default site for most patients. Fat coverage is generally consistent, the area is easy to see, and absorption is reliable. Use the soft tissue on either side of the belly button rather than directly above or below it.
2. Front or outer thigh. The middle portion of the thigh, on the front (anterior) or outer (lateral) side. The fat layer is usually adequate here, and the angle is comfortable for self-injection while seated. Avoid the inner thigh, which is more vascular, and the immediate area around the knee or hip.
3. Upper outer glute. The upper outer quadrant of the buttock, the same area used for many vaccinations. It is harder to reach without a mirror, but absorption is excellent and fat coverage tends to be deepest here. Some patients rotate this site in a couple of times a week to give the abdomen a rest.
4. Back of the deltoid. The fat pad on the back of the upper arm, just behind the deltoid muscle. Coverage varies a lot between patients. If you can pinch a half-inch or more of skin and fat here, it works. If the skin pulls tight against muscle, choose a different region.
Which Site Is Best?
There is no evidence that injecting CJC-1295/Ipamorelin near a particular body region changes the systemic effect. Once the peptides enter circulation through the subcutaneous fat, they act on the pituitary regardless of where the injection went in. So the choice comes down to comfort, absorption consistency, and how easy the site is to rotate within.
The abdomen is the practical default for exactly those reasons. Fat coverage is consistent, the angle is easy for self-injection, and the site is simple to see and subdivide for rotation. Most patients use the abdomen for the majority of injections and rotate to the thigh or glute periodically to spread the wear.
Practical Default
Use the abdomen as your primary site. Rotate to the thigh or upper glute every few injections. Skip the deltoid unless you have clear fat coverage there.
Timing: Bedtime, Empty Stomach
For this stack, timing does more work than site choice. Growth hormone releases in your deepest sleep stages, so a bedtime injection stacks the peptide-driven pulse on top of your natural nighttime rhythm. That is why nearly every CJC-1295/Ipamorelin protocol is a single evening dose rather than something spread through the day.
Teichman SL et al., "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults," J Clin Endocrinol Metab, 2006. View study
The empty-stomach rule matters just as much. Food, especially carbohydrates and fats, triggers insulin, and insulin blunts growth hormone secretion. Eating within one to two hours of the injection can meaningfully reduce the response. Practically, that means injecting at least a couple of hours after your last meal, which for most people lines up naturally with bedtime.
Iranmanesh A et al., "Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men," J Clin Endocrinol Metab, 1991. View study
Why Bedtime and Fasted
Bedtime aligns the dose with your natural GH pulse. An empty stomach keeps insulin low so it does not suppress the release. Together they are the point of the protocol, not optional extras.
Rotation Schedule
Repeated injection in the same spot causes minor fat-tissue trauma that adds up over weeks. The result is small palpable nodules, occasional bruising, or thickened tissue that absorbs the next injection less predictably. Rotation prevents this and keeps absorption consistent.
The rule most providers teach is to move at least one inch, a finger-width, from your last injection point every time. Within a single region you can subdivide into a grid: the abdomen has roughly eight usable spots if you split each side of the navel into quadrants. Cycle through them in order, then move to the next region.
A simple pattern for a once-nightly stack: work through the right side of the abdomen for a few nights, switch to the left side for a few more, then spend a couple of nights on the thigh before returning. Mark the previous spot with a fingernail indent if you cannot remember where you last injected. Give the abdomen an occasional week off by leaning on the thighs and glutes.
Technique That Reduces Site Reactions
The general subQ technique, warming the vial, pinching, slow injection, and brief post-injection pressure, is the same for this stack as for any other PeRx peptide and is covered in the how-to-inject-peptides guide. A couple of details are worth flagging for CJC-1295/Ipamorelin specifically.
Let the solution reach room temperature before injecting. A dose straight from the refrigerator is the most common reason a subQ injection stings. Draw it up, then let the syringe sit for a minute or two while you prep the site. This is easy to build into a bedtime routine.
Draw accurately, because the volume is small. The dose is a small fraction of an insulin syringe, so read the markings rather than estimating by eye. Getting the volume right is the difference between the prescribed dose and a partial one.
Inject slowly and hold brief pressure after. A slow, steady push is more comfortable than a fast one, and a few seconds of pressure with clean gauze afterward reduces the chance of a small bruise.
A Word on Dose
Your dose and schedule come from your provider, not from generic protocols online. CJC-1295/Ipamorelin is prescribed as a single evening subcutaneous injection on a provider-determined schedule, and the exact amount is on your prescription label. If you want the full picture of how the two peptides work together, benefits, timeline, and comparisons to alternatives, the CJC-1295/Ipamorelin stack guide covers it in depth.
Raun K et al., "Ipamorelin, the first selective growth hormone secretagogue," Eur J Endocrinol, 1998. View study
Common Pitfalls
Injecting after a late meal. Eating within one to two hours before the dose lets insulin blunt the GH response. Give it a gap, or shift the injection later.
Injecting through clothing. Even thin fabric is a contamination risk. Lift the shirt or waistband and inject into clean skin.
Using the same exact spot every night. Within a few weeks you will have a palpable lump and absorption will become inconsistent. Rotate.
Injecting into a tattoo, scar, mole, or visible vein. Avoid these sites entirely and pick clean skin a few inches away.
Reusing the needle. Insulin syringes are single use. Reusing dulls the needle, which makes injection more painful and increases tissue trauma. PeRx ships ample syringes with each order.
If you are weighing side effects before starting, the peptide side effects guide covers what is common, what is rare, and what deserves a call to your provider.
Frequently Asked Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Is CJC-1295/Ipamorelin FDA Approved? (2026 Answer)
The short answer is no. CJC-1295 and Ipamorelin are not FDA-approved drugs. They are compounded medications, prescribed by licensed providers and prepared by regulated pharmacies. Here is what that actually means for you, how it compares to FDA-approved peptides, and why the distinction matters less than most people think.
CJC-1295 + Ipamorelin: Growth Hormone Stack Guide
After age 30, your body produces roughly 15% less growth hormone every decade. This peptide stack doesn't replace what you've lost with synthetic hormones. It tells your body to start making more of its own again. One peptide carries the GHRH signal that primes release. The other fires the pulse. Together, they're the most popular growth hormone optimization protocol in peptide therapy.
Why We Pair CJC-1295 With Ipamorelin (No-DAC)
CJC-1295 and Ipamorelin act on two different receptors, so together they produce a bigger, cleaner growth-hormone pulse than either one alone. The detail most people miss: we use the no-DAC version of CJC-1295 on purpose. That choice is what keeps the release pulsatile and physiologic instead of a flat, all-day elevation. Here is the reasoning behind the pairing.
Ready to get started?
Pharmaceutical-grade CJC-1295/Ipamorelin, prescribed by a licensed provider and shipped to your door fully reconstituted and ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.
Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026